End-of-day quote
Korea S.E.
23:00:00 13/05/2024 BST
|
5-day change
|
1st Jan Change
|
383
KRW
|
+0.26%
|
|
-0.78%
|
-3.04%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
94,556
|
92,304
|
415,719
|
158,773
|
56,500
|
68,906
|
Enterprise Value (EV)
1 |
123,213
|
130,320
|
433,703
|
174,211
|
55,300
|
97,255
|
P/E ratio
|
3
x
|
-2.69
x
|
-39.1
x
|
-3.72
x
|
-4.69
x
|
13.6
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
3.2
x
|
5.21
x
|
18
x
|
4.42
x
|
1.37
x
|
1.51
x
|
EV / Revenue
|
4.17
x
|
7.35
x
|
18.7
x
|
4.85
x
|
1.34
x
|
2.14
x
|
EV / EBITDA
|
-237
x
|
-14.8
x
|
-53.6
x
|
-15.8
x
|
-23.8
x
|
-7.8
x
|
EV / FCF
|
-8.42
x
|
-7.65
x
|
29.3
x
|
-8.92
x
|
-24.4
x
|
-3.73
x
|
FCF Yield
|
-11.9%
|
-13.1%
|
3.41%
|
-11.2%
|
-4.1%
|
-26.8%
|
Price to Book
|
0.75
x
|
0.86
x
|
3.24
x
|
1.66
x
|
0.57
x
|
0.64
x
|
Nbr of stocks (in thousands)
|
88,370
|
94,671
|
138,113
|
145,663
|
162,825
|
174,446
|
Reference price
2 |
1,070
|
975.0
|
3,010
|
1,090
|
347.0
|
395.0
|
Announcement Date
|
21/03/19
|
18/03/20
|
19/03/21
|
21/03/22
|
23/03/23
|
21/03/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
29,535
|
17,725
|
23,143
|
35,915
|
41,286
|
45,501
|
EBITDA
1 |
-520.9
|
-8,791
|
-8,093
|
-11,054
|
-2,320
|
-12,474
|
EBIT
1 |
-1,143
|
-10,451
|
-9,275
|
-12,227
|
-3,659
|
-14,597
|
Operating Margin
|
-3.87%
|
-58.96%
|
-40.08%
|
-34.04%
|
-8.86%
|
-32.08%
|
Earnings before Tax (EBT)
1 |
37,827
|
-37,044
|
-10,230
|
-41,916
|
-12,052
|
-8,762
|
Net income
1 |
33,768
|
-33,443
|
-8,713
|
-41,601
|
-11,621
|
5,050
|
Net margin
|
114.33%
|
-188.68%
|
-37.65%
|
-115.83%
|
-28.15%
|
11.1%
|
EPS
2 |
357.0
|
-362.5
|
-77.00
|
-293.0
|
-74.00
|
29.00
|
Free Cash Flow
1 |
-14,636
|
-17,026
|
14,798
|
-19,521
|
-2,268
|
-26,052
|
FCF margin
|
-49.56%
|
-96.06%
|
63.94%
|
-54.35%
|
-5.49%
|
-57.26%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
21/03/19
|
18/03/20
|
19/03/21
|
21/03/22
|
23/03/23
|
21/03/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
28,658
|
38,016
|
17,984
|
15,438
|
-
|
28,349
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
1,201
|
-
|
Leverage (Debt/EBITDA)
|
-55.02
x
|
-4.324
x
|
-2.222
x
|
-1.397
x
|
-
|
-2.273
x
|
Free Cash Flow
1 |
-14,636
|
-17,026
|
14,798
|
-19,521
|
-2,268
|
-26,052
|
ROE (net income / shareholders' equity)
|
30.7%
|
-29%
|
-8.44%
|
-38%
|
-12.6%
|
-8.03%
|
ROA (Net income/ Total Assets)
|
-0.45%
|
-3.62%
|
-3.51%
|
-5.09%
|
-1.76%
|
-6.02%
|
Assets
1 |
-7,584,842
|
924,777
|
248,538
|
816,943
|
661,184
|
-83,898
|
Book Value Per Share
2 |
1,433
|
1,132
|
928.0
|
657.0
|
613.0
|
618.0
|
Cash Flow per Share
2 |
203.0
|
113.0
|
9.010
|
67.70
|
119.0
|
42.50
|
Capex
1 |
201
|
2,524
|
3,244
|
17,101
|
40.5
|
3,031
|
Capex / Sales
|
0.68%
|
14.24%
|
14.02%
|
47.61%
|
0.1%
|
6.66%
|
Announcement Date
|
21/03/19
|
18/03/20
|
19/03/21
|
21/03/22
|
23/03/23
|
21/03/24
|
|
1st Jan change
|
Capi.
|
---|
| -3.04% | 48.96M | | +17.30% | 66.22B | | +3.54% | 49.24B | | +18.03% | 41.4B | | +21.48% | 26.62B | | +13.22% | 19.84B | | +2.29% | 17.44B | | -11.87% | 15.92B | | -23.54% | 15.57B | | +2.57% | 15.45B |
Other Specialty Chemicals
|